Atorvastatin September update for anyone taking for high cholesterol in UK after test results

Atorvastatin reduced major cardiovascular event risk by 30% compared with placebo but ‘death risk’ remained same Atorvastatin reduced major cardiovascular event risk by 30% compared with placebo but ‘death risk’ remained same Lancs Live – NewsRead More 

Similar Posts